Bruno Nahar

May 1, 2024 | auajournals.org | Yuval Avda |Ruben Blachman-Braun |Bruno Nahar |Sabika Sadiq

INTRODUCTION AND OBJECTIVE: Bladder sarcomas are a rare group of malignancies, with most of the data published comprised mostly of single center cohorts. This National Cancer Data Base (NCDB) is a national hospital-based registry, that includes more the 1,500 sites. In this study we used the NCDB to explore bladder sarcomas in the United States, utilizing the database advantages of its size, breadth, and inclusion of treatments given, as well as survival.